You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Healthy Chinese subjects

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

The Effects of Clarithromycin or Cyclosporine on Pharmacokinetics of Deuterium Hydrobromide Ramidvir Tablets in Healthy Chinese

Active, not recruiting
  • The Effects of Clarithromycin or Cyclosporine on Pharmacokinetics of Deuterium Hydrobromide Ramidvir Tablets in Healthy Chinese Subjects
  • Mindeudesivir hydrobromide tablets and Clarithromycin tablets
  • Mindeudesivir hydrobromide tablets and Cyclosporine softgels
  • Zhengzhou, Henan, China
    Zhengzhou Sixth People's Hospital
Aug 15, 2023

Healthy Trial in Sichuan (THDB0206 injection, Humalog®, BC222insulin lispro injection)

Completed
  • Healthy
  • THDB0206 injection
  • +2 more
  • Sichuan, China
    West China Hospital of Sichuan University
Nov 22, 2023

Healthy Volunteers Trial (TY-9591)

Not yet recruiting
  • Healthy Volunteers
  • (no location specified)
May 15, 2023

COVID-19 Trial (STI-1558)

Not yet recruiting
  • COVID-19
  • (no location specified)
Sep 15, 2023

Healthy Volunteer Trial in Wuhan (GFH312 100 mg, GFH312 200 mg, GFH312 120mg)

Completed
  • Healthy Volunteer
  • GFH312 100 mg
  • +3 more
  • Wuhan, Hubei, China
    Union Hospital, Tongji Medical College, Huazhong University of S
Aug 6, 2023

Therapeutic Equivalency Trial in Qingdao (Tested Irbesartan Tablet, Reference Irbesartan Tablet)

Completed
  • Therapeutic Equivalency
  • Tested Irbesartan Tablet
  • Reference Irbesartan Tablet
  • Qingdao, Shandong, China
    Affiliated Hospital of Qingdao University Phase I Clinical Resea
Mar 24, 2023

Asthma Trial in Sichuan (HBM9378 (SKB378) Injection, Placebo)

Recruiting
  • Asthma
  • HBM9378 (SKB378) Injection
  • Placebo
  • Sichuan, Chengdu, China
    The Fifth People's Hospital of Chengdu
Mar 16, 2023

Healthy Trial (Test (T) Bilastine, Reference (R) Bilastine)

Not yet recruiting
  • Healthy
  • Test (T) Bilastine
  • Reference (R) Bilastine
  • (no location specified)
Oct 19, 2023

Healthy Trial (SSS40, Placebo)

Not yet recruiting
  • Healthy
  • (no location specified)
Aug 27, 2023

COPD Trial in Changsha (Ensifentrine)

Not yet recruiting
  • Chronic Obstructive Pulmonary Disease
  • Changsha, Hunan, China
    The Third Hospital of Changsha
Feb 24, 2023

Healthy Volunteers Trial in Grayslake (Lutikizumab Dose A, Lutikizumab Dose B)

Recruiting
  • Healthy Volunteers
  • Lutikizumab Dose A
  • Lutikizumab Dose B
  • Grayslake, Illinois
    Acpru /Id# 259029
Oct 4, 2023

Healthy Volunteers Trial in Shanghai (TAK-279, Placebo)

Not yet recruiting
  • Healthy Volunteers
  • Shanghai, China
    Huashan Hospital Fudan University
Oct 27, 2023

Atopic Dermatitis Trial in Hangzhou (TLL-018 extended-release tablet, TLL-018 immediate-release tablet)

Active, not recruiting
  • Atopic Dermatitis
  • TLL-018 extended-release tablet
  • TLL-018 immediate-release tablet
  • Hangzhou, Zhejiang, China
    The Second Affiliated Hospital Zhejiang University School of Med
Jul 12, 2023

Healthy Chinese Subjects Trial in Shanghai (Etripamil Nasal Spray 70mg, Placebo)

Not yet recruiting
  • Healthy Chinese Subjects
  • Etripamil Nasal Spray 70mg
  • Placebo
  • Shanghai, Shanghai, China
    Huashan Hospital Affiliated to Fudan University
Aug 22, 2022

Asthma Trial in Hangzhou (JYB1904, Omalizumab, JYB1904 Placebo)

Active, not recruiting
  • Asthma
  • Hangzhou, Zhejiang, China
    Shulan (Hangzhou) Hospital
Oct 23, 2022

Healthy Trial (Test (T) Entacapone,Levodopa and Carbidopa Tablets (II), Reference (R) Entacapone,Levodopa and Carbidopa Tablets

Not yet recruiting
  • Healthy
  • Test (T) Entacapone,Levodopa and Carbidopa Tablets (II)
  • Reference (R) Entacapone,Levodopa and Carbidopa Tablets (II)
  • (no location specified)
Jul 26, 2023

Breast Cancer Trial in Suzhou ([14C] TQB3616)

Not yet recruiting
  • Breast Cancer
  • [14C] TQB3616
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Nov 21, 2023

Healthy Subjects Trial in Suzhou (NBL-012 Injection, Placebo)

Completed
  • Healthy Subjects
  • NBL-012 Injection
  • Placebo
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University.
Jul 19, 2022

COVID-19 Trial (F61 injection, F61 Placebo)

Not yet recruiting
  • COVID-19
  • F61 injection
  • F61 Placebo
  • (no location specified)
Jul 29, 2022

Healthy Trial in Qingdao (Test Empagliflozin And Linagliptin Tablets, Reference Empagliflozin And Linagliptin tablets)

Completed
  • Healthy
  • Test Empagliflozin And Linagliptin Tablets
  • Reference Empagliflozin And Linagliptin tablets
  • Qingdao, Shandong, China
    The Affiliated Hospital of Qingdao University Phase I Clinical R
Jul 14, 2023

Lymphoma Trial ([14C]SHR2554)

Not yet recruiting
  • Lymphoma
  • (no location specified)
Aug 20, 2023

Healthy Volunteers Trial in Hong Kong (Ketorolac Tromethamine)

Recruiting
  • Healthy Volunteers
  • Ketorolac Tromethamine
  • Hong Kong, Hong Kong, China
    HUK Phase 1 clinical trials center
Jun 21, 2022

Healthy Trial in Qingdao (reference eldecalcitol soft capsule, test eldecalcitol soft capsule)

Completed
  • Healthy
  • reference eldecalcitol soft capsule
  • test eldecalcitol soft capsule
  • Qingdao, Shandong, China
    The Affiliated Hospital of Qingdao University
Jun 1, 2022

Healthy Trial in Qingdao (test apixaban tablets, reference apixaban tablets)

Completed
  • Healthy
  • test apixaban tablets
  • reference apixaban tablets
  • Qingdao, Shandong, China
    The Affiliated Hospital of Qingdao University Phase I Clinical R
May 1, 2023

Healthy Subjects Trial in Shanghai (Part A ABSK201 and Itraconazole, Part A ABSK201 and Rifampicin)

Enrolling by invitation
  • Healthy Subjects
  • Part A ABSK201 and Itraconazole
  • Part A ABSK201 and Rifampicin
  • Shanghai, Shanghai, China
    Huashan Hospital Fudan University
Oct 12, 2023